Franklin Templeton is charting a course through a rapidly evolving asset management landscape, marked by bold digital initiatives and strategic portfolio adjustments. The firm’s latest quarterly results, however, underscore the challenges inherent in this period of transition.
Strategic Alliances Drive Digital Ambition
In a significant move to establish a foothold in the digital asset space, Franklin Templeton has entered a partnership with major bank DBS and blockchain technology firm Ripple. The collaboration, announced on Saturday, is designed to deliver innovative trading and credit solutions for institutional investors by leveraging XRP Ledger technology. Central to this initiative are tokenized money-market funds that will utilize the Ripple USD Stablecoin (RLUSD) and the sgBENJI token.
This alliance represents a proactive effort to capture a share of the growing digital finance market, positioning the firm ahead of many competitors who have been slower to embrace tokenized financial products.
Quarterly Performance Reflects Market Pressures
The firm’s strategic developments unfold against a backdrop of operational headwinds. Third-quarter earnings (period ending June) revealed an earnings per share (EPS) of $0.49, which slightly surpassed expectations of $0.48. Nonetheless, this figure was notably lower than the $0.60 EPS reported for the same quarter the previous year. The results were impacted by reduced revenue and increased operational expenses.
A positive note was a rise in assets under management, which climbed to $1.64 trillion by the end of August. This growth was fueled by favorable market movements and new investor inflows, though these gains were partially offset by continuing outflows from the Western Asset Management division.
Should investors sell immediately? Or is it worth buying Franklin?
ETF Rationalization: Exiting a Niche Strategy
In a contrasting move to its digital expansion, Franklin Templeton is scaling back in other areas. The firm disclosed on Friday its decision to liquidate the Putnam BioRevolution™ ETF (SYNB). The fund, which focused on early-stage biotechnology companies, delivered a disappointing 12-month performance of -5.95% and failed to attract sufficient capital. Trading is expected to be halted on November 14, with a final dissolution scheduled for approximately one week later.
This termination reflects a broader industry trend where asset managers are streamlining their product offerings, shedding underperforming and niche strategies to concentrate on more profitable core products.
Expanding Access to Private Infrastructure
Beyond digital assets, Franklin Templeton is also broadening its focus on private markets. A newly formed partnership with Copenhagen Infrastructure Partners, DigitalBridge, and Actis aims to provide individual investors with access to private infrastructure investments, a market traditionally dominated by institutional capital.
The potential of this sector is substantial, with an estimated $94 trillion expected to be invested in global infrastructure projects by 2040. Private investors are projected to contribute approximately $15 trillion of this total. The investment focus will center on megatrends such as energy security, electrification, and digitalization—areas known for generating stable, inflation-resistant cash flows and long-term resilience, which are particularly valuable in uncertain economic climates.
Franklin Templeton’s current strategy illustrates a multi-faceted approach to growth, balancing ambitious technological partnerships with a pragmatic reassessment of its existing product lineup. The effectiveness of this balanced strategy will become clearer in subsequent financial quarters.
Ad
Franklin Stock: Buy or Sell?! New Franklin Analysis from September 20 delivers the answer:
The latest Franklin figures speak for themselves: Urgent action needed for Franklin investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 20.
Franklin: Buy or sell? Read more here...